12882_2017_572_MOESM1_ESM.docx (18.95 kB)
Additional file 1: Table S1. of Identification of chronic kidney disease patient characteristics influencing the renoprotective effects of febuxostat therapy: a retrospective follow-up study
journal contribution
posted on 2017-05-18, 05:00 authored by Akinori Yamaguchi, Makoto Harada, Yosuke Yamada, Koji Hashimoto, Yuji KamijoAdverse events. There were 15 cases wherein febuxostat treatment was discontinued owing to various adverse events. In most patients, the adverse events developed during the initial dosing of febuxostat at 10Â mg/day. (DOCX 18Â kb)